Factors associated with decreased kidney function in HIV-infected adults enrolled in the MTCT-plus initiative in sub-Saharan Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 1, 2011, Pages 40-45

  Jao, Jennifer ^a   Lo, Wilson ^b   Toro, Patricia L ^c   Wyatt, Christina ^a   Palmer, Dennis ^d   Abrams, Elaine J ^c   Carter, Rosalind J ^c  

^a MOUNT SINAI HOSPITAL   (United States)

^b TUBERCULOSIS AND MALARIA   (Switzerland)

^c Columbia University ^*  (United States)

^d Mbingo Baptist Hospital   (Cameroon)

Author keywords

Africa; creatinine clearance; glomerular filtration rate; HIV; kidney; prevalence

Indexed keywords

CREATININE;

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CREATININE CLEARANCE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AFRICA SOUTH OF THE SAHARA; COHORT STUDIES; CREATININE; FEMALE; HIV; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; PREVALENCE; RISK FACTORS;

EID: 79955037972     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821008eb     Document Type: Article

References (23)

1. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559-1585. (Pubitemid 40720806)
2. Wyatt CM, Klotman PE. HIV-associated nephropathy in the era of antiretroviral therapy. Am J Med. 2007;120:488-492. (Pubitemid 46764627)
3. Choi AI, Rodriguez RA, Bacchetti P, et al. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol. 2007;18:2968-2974. (Pubitemid 350058405)
4. Lucas GM, Lau B, Atta MG, et al. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008;197:1548-1557. (Pubitemid 351706485)
5. Lucas GM, Clarke W, Kagaayi J, et al. Decreased kidney function in a community-based cohort of HIV-infected and HIV-negative individuals in Rakai, Uganda. J Acquir Immune Defic Syndr. 2010.
6. Emem CP, Arogundade F, Sanusi A, et al. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008;23:741-746. (Pubitemid 351767653)
7. Reid A, Stohr W, Walker AS, et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008;46:1271-1281. (Pubitemid 351589914)
8. Mulenga LB, Kruse G, Lakhi S, et al. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. AIDS. 2008;22:1821-1827.
9. Stohr W, Walker AS, Munderi P, et al. Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae. Antivir Ther. 2008;13: 761-770.
10. WHO. 2010 Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. Available at: http://www.who.int/hiv/pub/arv/adult2010/en/index.html. Accessed October 7, 2010.
11. Gitman MD, Hirschwerk D, Baskin CH, et al. Tenofovir-induced kidney injury. Expert Opin Drug Saf. 2007;6:155-164. (Pubitemid 46380809)
12. Fux CA, Simcock M, Wolbers M, et al. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antivir Ther. 2007;12:1165-1173.
13. Young B, Buchacz K, Baker RK, et al. Renal function in tenofovir-exposed and tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV outpatient study. J Int Assoc Physicians AIDS Care (Chic Ill). 2007;6:178-187.
14. Myer L, Rabkin M, Abrams EJ, et al. Focus on women: linking HIV care and treatment with reproductive health services in the MTCT-Plus Initiative. Reprod Health Matters. 2005;13:136-146. (Pubitemid 40813260)
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
16. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
17. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
18. Wools-Kaloustian K, Gupta SK, Muloma E, et al. Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant. 2007;22:2208-2212. (Pubitemid 47248464)
19. Peters PJ, Moore DM, Mermin J, et al. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int. 2008;74: 925-929.
20. National Kidney Foundation. National Kidney Foundation Kidney Disease Outcome Quality Initiative. 2002. Available at: www.kdoqi.org. Accessed August 1, 2010.
21. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351:1296-1305.
22. Eastwood JB, Kerry SM, Plange-Rhule J, et al. Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations. Nephrol Dial Transplant. 2010;25: 2178-2187.
23. van Deventer HE, George JA, Paiker JE, et al. Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations. Clin Chem. 2008;54: 1197-1202. (Pubitemid 352009697)